Status:

COMPLETED

Nicotinamide Riboside on Mitochondrial Function in Li-Fraumeni Syndrome

Lead Sponsor:

National Heart, Lung, and Blood Institute (NHLBI)

Conditions:

Cancer

Skin Fibroblasts

Eligibility:

All Genders

18-70 years

Phase:

PHASE1

PHASE2

Brief Summary

Background: Nicotinamide riboside (NR) is a vitamin B3 dietary supplement. It may help improve muscle function, that may in turn may improve a person s exercise capacity. Researchers want to study ho...

Detailed Description

We have previously reported that inherited mutations of TP53, which causes the premature cancer disorder Li-Fraumeni syndrome (LFS), can promote mitochondrial function both in patients and mouse model...

Eligibility Criteria

Inclusion

  • INCLUSION CRITERIA:
  • At least 18-years of age and able to give informed consent
  • Have delayed phosphocreatine (PCr) recovery time constant \>45 sec by 31P-magnetic resonance spectroscopy (MRS) testing and a history of fatigue symptoms
  • Ability to undergo study procedures, including scheduled visits, blood draws and skeletal muscle exercise Nuclear Magnetic Resonance (NMR)
  • Have Li-Fraumeni syndrome and confirmed TP53 mutation by genetic testing
  • Committed to using reliable contraception which may include abstinence during study participation
  • Female participants of child-bearing ability and potential willing to commit to reliable contraception while participating in the study
  • EXCLUSION CRITERIA:
  • Current systemic treatment for cancer
  • Unable to perform required study visits or procedures
  • Magnetic resonance imaging (MRI) incompatible hardware
  • Pregnant or breastfeeding women
  • History of intolerance to NR precursor compounds, including niacin or nicotinamide

Exclusion

    Key Trial Info

    Start Date :

    March 25 2019

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    November 1 2019

    Estimated Enrollment :

    1 Patients enrolled

    Trial Details

    Trial ID

    NCT03789175

    Start Date

    March 25 2019

    End Date

    November 1 2019

    Last Update

    December 8 2020

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    National Institutes of Health Clinical Center

    Bethesda, Maryland, United States, 20892